MIF-1

Experimental Peptide

MIF-1, also called melanocyte-inhibiting factor-1, is the tripeptide Pro-Leu-Gly-NH2. Most evidence is old and preclinical; it does not support self-treatment of depression or a human dosing recommendation.

Pharmacokinetic model

A route-level PK model for mif-1 is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.

Key facts

Category
Experimental Peptide
Suggested cadence
once daily

Research behind this entry

  1. MIF-1 is active in a chronic stress animal model of depression Pignatiello MF, Olson GA, Kastin AJ, Ehrensing RH, McLean JH, Olson RD · Pharmacology, Biochemistry, and Behavior, 1989 DOI

    Rats exposed to unpredictable chronic stress received daily intraperitoneal MIF-1. Low doses changed open-field measures in the same direction as imipramine, while a high dose worsened stress effects and produced…

1 published study referenced in the app, each with a plain-language summary.